Bioline Rx (BLRX) Financial Statements

2 Followers

Bioline Rx Financial Overview

Bioline Rx's market cap is currently ₪33.94M. The company's EPS TTM is 0; its P/E ratio is -9.73; Bioline Rx is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is -0.60. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 1.28M	$ 28.94M	$ 4.80M	$ 0.00	$ 0.00
Gross Profit	$ 462.21K	$ 19.68M	$ 1.11M	$ 0.00	$ 0.00
Operating Income	$ -11.14M	$ -20.41M	$ -49.69M	$ -29.16M	$ -24.78M
EBITDA	$ -10.57M	$ 3.92M	$ -57.09M	$ -28.50M	$ -24.07M
Net Income	$ -1.27M	$ -9.22M	$ -60.61M	$ -20.75M	$ -28.14M
Balance Sheet
Cash & Short-Term Investments	$ 20.88M	$ 19.56M	$ 42.99M	$ 51.08M	$ 57.13M
Total Assets	$ 40.91M	$ 38.91M	$ 63.92M	$ 76.38M	$ 81.39M
Total Debt	$ 10.15M	$ 15.04M	$ 11.59M	$ 12.32M	$ 4.65M
Net Debt	$ 6.90M	$ 4.60M	$ 7.34M	$ 1.74M	$ -8.34M
Total Liabilities	$ 17.56M	$ 25.45M	$ 50.70M	$ 25.54M	$ 13.30M
Stockholders' Equity	$ 18.20M	$ 13.46M	$ 13.22M	$ 50.84M	$ 68.09M
Cash Flow
Free Cash Flow	$ -8.77M	$ -43.93M	$ -22.91M	$ -26.56M	$ -23.67M
Operating Cash Flow	$ -8.74M	$ -43.87M	$ -22.61M	$ -26.24M	$ -23.57M
Investing Cash Flow	$ -9.25M	$ 29.37M	$ 1.44M	$ 4.01M	$ -38.22M
Financing Cash Flow	$ 9.62M	$ 20.66M	$ 15.06M	$ 20.44M	$ 57.75M

Currency in USD

Bioline Rx Earnings and Revenue History

Income Statement >

Bioline Rx Debt to Assets

Balance Sheet >

Bioline Rx Cash Flow

Cash Flow >

Bioline Rx Forecast EPS vs Actual EPS

Earnings >